Pediatrix Medical Group, Inc. MD

FY2025 · ended Dec 31, 2025 · Revenue $1.91B, -4.9% YoY · Filed Feb 19, 2026

Pediatrix Medical Group, Inc. (MD) files with the SEC under industry code 8060, Services-Hospitals. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $1.9 billion and net income of $165.4 million. As of Sep 30, 2026 it held $425.8 million in cash and investments and $432.1 million in total debt.

Revenue (TTM)
$1.96B
+1.9% vs year-ago TTM
Net income (TTM)
$150.09M
-7.5% vs year-ago TTM
Operating cash flow (TTM)
$226.88M
-21.8% vs year-ago TTM
Free cash flow
—
EPS (TTM)
$1.83
-4.2% vs year-ago TTM
Dividend per share
None
Shares outstanding
83.00M
-3.3% vs prior year
Net cash
$-6.22M
as of Sep 30, 2026
Operating margin
10.9%
FY 2026

Company profile

Industry
Services-Hospitals (SIC 8060)
Listed as
MD (NYSE)
Fiscal year ends
December 31
Incorporated in
FL
Headquarters
Sunrise, FL
SEC filer status
Large accelerated filer
SEC CIK
893949
Former names
MEDNAX, INC. (until Jun 21, 2022); PEDIATRIX MEDICAL GROUP INC (until Jan 2, 2009)

Other Services-Hospitals companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

Line
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
Revenue
$1.9B
$2.0B
$2.0B
$2.0B
$1.9B
Operating income
$208.8M
-$68.7M
$7.3M
$172.7M
$202.9M
Net income
$165.4M
-$99.1M
-$60.4M
$66.3M
$131.0M
Diluted EPS
$1.94
-$1.19
-$0.73
$0.79
$1.53
Operating cash flow
$271.1M
$206.6M
$137.3M
$166.9M
$76.7M
Total assets
$2.2B
$2.2B
$2.2B
$2.3B
$2.7B
Total liabilities
$1.4B
$1.4B
$1.4B
$1.5B
$1.8B
Stockholders' equity
$865.9M
$764.9M
$849.1M
$891.6M
$896.5M
Cash and investments
$499.7M
$348.5M
$177.7M
$103.1M
$487.1M
Total debt
$637.5M
$661.2M
$699.8M
$714.1M
$1.1B

Recent SEC filings

Recent SEC filings
Form Description Filed Period
10-Q Quarterly report Oct 29, 2026 Sep 30, 2026
8-K Current report
Results of operations
Oct 29, 2026 Oct 29, 2026
10-Q Quarterly report Aug 4, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 4, 2026 Aug 4, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Jul 24, 2026 Jul 21, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Jul 15, 2026 Jul 15, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.